| 8843- | DIM, | 3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis |
| - | in-vitro, | NSCLC, | NA |
| 8856- | DIM, | DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism |
| - | in-vivo, | Nor, | NA |
| 8855- | DIM, | A therapeutically relevant, 3,3'-diindolylmethane derivative NGD16 attenuates angiogenesis by targeting glucose regulated protein, 78kDa (GRP78) |
| - | vitro+vivo, | Pca, | PC3 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | CRC, | COLO205 | - | in-vitro, | Nor, | HUVECs |
| 8854- | DIM, | Rad, | 3,3′-Diindolylmethane: A Promising Sensitizer of γ-Irradiation |
| - | in-vitro, | BC, | MCF7 |
| 8853- | DIM, | Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies |
| - | Review, | Var, | NA |
| - | in-vitro, | ESCC, | TE1 | - | in-vitro, | ESCC, | KYSE-30 |
| 8851- | DIM, | 3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs |
| - | Review, | Var, | NA |
| 8850- | DIM, | 3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8849- | DIM, | I3C, | Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane |
| - | Review, | Var, | NA |
| 8848- | DIM, | 5-FU, | 3,3′-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer |
| - | vitro+vivo, | CRC, | DLD1 | - | in-vitro, | CRC, | HCT116 |
| 8847- | DIM, | Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells |
| - | in-vitro, | BC, | NA |
| 8846- | DIM, | ORM, | Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach |
| - | vitro+vivo, | BC, | NA |
| 8845- | DIM, | I3C, | 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways |
| - | Review, | Var, | NA |
| 8844- | DIM, | I3C, | Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 8841- | DIM, | 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis |
| - | in-vitro, | Liver, | Hep3B | - | in-vitro, | Liver, | HUH7 |
| 4984- | Dipy, | ATV, | Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop |
| - | in-vitro, | AML, | NA |
| 4990- | Dipy, | Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management |
| - | in-vivo, | Nor, | NA |
| 4989- | Dipy, | Dipyridamole |
| - | Review, | Nor, | NA |
| 4987- | Dipy, | ATV, | Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination |
| - | in-vivo, | Nor, | NA |
| 4983- | Dipy, | ATV, | Targeting tumor cell metabolism via the mevalonate pathway: Two hits are better than one |
| - | Review, | Var, | NA |
| 6732- | Dipy, | Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway |
| - | in-vivo, | Nor, | NA |
| 6729- | Dipy, | Dipyridamole prevents triple-negative breast-cancer progression |
| - | Trial, | BC, | MDA-MB-231 |
| 6730- | Dipy, | ASA, | Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner |
| - | vitro+vivo, | CRC, | NA |
| 6731- | Dipy, | Dipyridamole, an underestimated vascular protective drug |
| - | Review, | Nor, | NA |
| 6733- | Dipy, | Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress |
| - | in-vivo, | Diabetic, | NA |
| 6734- | Dipy, | Cisplatin, | Adenosine enhances cisplatin sensitivity in human ovarian cancer cells |
| - | in-vitro, | Ovarian, | NA |
| 6735- | Dipy, | Dipyridamole Reverses Peripheral Ischemia and Induces Angiogenesis in the Db/Db Diabetic Mouse Hind Limb Model by Decreasing Oxidative Stress |
| - | in-vivo, | Nor, | NA |
| 6736- | Dipy, | Nucleoside Transport Inhibition by Dipyridamole Prevents Angiogenesis Impairment by Homocysteine and Adenosine |
| - | in-vitro, | Nor, | NA |
| 6737- | Dipy, | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD) |
| - | Trial, | Nor, | NA |
| 6278- | DL, | Safety evaluation and risk assessment of d-Limonene |
| - | Review, | Nor, | NA |
| 6289- | DL, | D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis |
| - | in-vivo, | Var, | NA |
| 6290- | DL, | Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells |
| - | in-vitro, | AML, | K562 | - | in-vitro, | AML, | HL-60 |
| 6265- | DL, | Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee |
| - | Trial, | Var, | NA |
| 6266- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer |
| - | Trial, | BC, | NA |
| 6267- | DL, | Effect of d-limonene and its derivatives on breast cancer in human trials: a scoping review and narrative synthesis |
| - | Review, | BC, | NA |
| 6268- | DL, | Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2) |
| - | in-vitro, | Liver, | HepG2 |
| 6269- | DL, | Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells |
| - | in-vitro, | CRC, | LS174T |
| 6270- | DL, | d-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1299 |
| 6271- | DL, | D-limonene rich volatile oil from blood oranges inhibits angiogenesis, metastasis and cell death in human colon cancer cells |
| - | in-vitro, | Colon, | SW480 | - | in-vitro, | Colon, | HT-29 |
| 6272- | DL, | Anti‐leukemic and anti‐angiogenic effects of d‐Limonene on K562‐implanted C57BL/6 mice and the chick chorioallantoic membrane model |
| - | vitro+vivo, | CLL, | NA |
| 6273- | DL, | D-Limonene Exhibits Antiproliferative Activity Against Human Colorectal Adenocarcinoma (Caco-2) Cells via Regulation of Inflammatory and Apoptotic Pathways |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | Colon, | HCT116 |
| 6274- | DL, | Protective Effect of D-Limonene against Oxidative Stress-Induced Cell Damage in Human Lens Epithelial Cells via the p38 Pathway |
| - | in-vitro, | Nor, | NA |
| 6275- | DL, | Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans |
| - | in-vivo, | Col, | NA |
| 6277- | DL, | docx, | d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | PZ-HPV-7 |
| 6288- | DL, | From Citrus to Clinic: Limonene’s Journey Through Preclinical Research, Clinical Trials, and Formulation Innovations |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6287- | DL, | D-Limonene Is a Potential Monoterpene to Inhibit PI3K/Akt/IKK-α/NF-κB p65 Signaling Pathway in Coronavirus Disease 2019 Pulmonary Fibrosis |
| - | in-vivo, | Covid, | NA |
| 6286- | DL, | d-Limonene inhibits cytokines and chemokines expression by regulating NF-kappaB and STAT in HaCat cells and DNCB-induced atopic dermatitis in BALB/c mice |
| - | in-vitro, | Nor, | NA |
| 6285- | DL, | Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 6284- | DL, | Chemoprevention and therapy of cancer by d-limonene |
| - | in-vivo, | Var, | NA |
| 6282- | DL, | Limonene Exerts Anti-Inflammatory Effect on LPS-Induced Jejunal Injury in Mice by Inhibiting NF-κB/AP-1 Pathway |
| - | in-vivo, | IBD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid